Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis

L Liou, S Kaptoge - PloS one, 2020 - journals.plos.org
Objectives The aim of this study was to systematically collate and appraise the available
evidence regarding the associations between small, dense low-density lipoprotein (sdLDL) …

Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association

XS Cheng, LB VanWagner, SP Costa, DA Axelrod… - Circulation, 2022 - Am Heart Assoc
Coronary heart disease is an important source of mortality and morbidity among kidney
transplantation and liver transplantation candidates and recipients and is driven by …

Small, dense low-density lipoprotein-cholesterol and atherosclerosis: relationship and therapeutic strategies

X Jin, S Yang, J Lu, M Wu - Frontiers in cardiovascular medicine, 2022 - frontiersin.org
Low-density lipoprotein cholesterol (LDL-C) plays an important role in the formation,
incidence, and development of atherosclerosis (AS). Low-density lipoproteins can be …

Adverse effects of immunosuppression after liver transplantation

J Noble, F Terrec, P Malvezzi, L Rostaing - Best Practice & Research …, 2021 - Elsevier
After solid organ transplantation the cornerstone of immunosuppression is based on
calcineurin inhibitors (CNIs), mostly tacrolimus. However, CNIs have a very narrow …

Saroglitazar, a dual PPAR α/γ agonist, improves atherogenic dyslipidemia in patients with non-cirrhotic nonalcoholic fatty liver disease: a pooled analysis

MS Siddiqui, D Parmar, F Sheikh, SK Sarin… - Clinical …, 2023 - Elsevier
Background & Aims Cardiovascular disease is the leading cause of mortality in nonalcoholic
fatty liver disease (NAFLD). The aim of this study was to evaluate the effects of saroglitazar …

[PDF][PDF] The impact of coronary artery disease and statins on survival after liver transplantation

SS Patel, VA Rodriguez, MB Siddiqui… - Liver …, 2019 - Wiley Online Library
Cardiovascular disease (CVD) is a major contributor to longterm mortality after liver
transplantation (LT) necessitating aggressive modification of CVD risk. However, it is unclear …

[HTML][HTML] Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations

M Izzy, BE Fortune, M Serper, N Bhave… - American journal of …, 2022 - Elsevier
Cardiac diseases are one of the most common causes of morbidity and mortality following
liver transplantation (LT). Prior studies have shown that cardiac diseases affect close to one …

Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients

MS Siddiqui, D Parmar, F Shaikh, M Forsgren… - Liver …, 2023 - journals.lww.com
NAFLD is common after liver transplantation (LT) and is associated with an increased
metabolic burden. Currently, there is a paucity of investigations into the treatment of post-LT …

Extrahepatic manifestations of nonalcoholic fatty liver disease

J Wattacheril - Gastroenterology Clinics, 2020 - gastro.theclinics.com
NAFLD represents a clinicopathologic spectrum of disease with distinct subtypes.
Independent of other causes of intrahepatic lipid accumulation including alcohol, the …

[HTML][HTML] Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal …

SO Nomura, AB Karger, P Garg, J Cao, H Bhatia… - American journal of …, 2023 - Elsevier
Objective This study compared small dense low-density lipoprotein cholesterol (sdLDL-C)
with apolipoprotein B (apo B), and low-density lipoprotein particles (LDL-P) in predicting …